Prognostic impact of 6 min walk test distance in patients with systolic heart failure: insights from the WARCEF trial

Prognostic impact of 6 min walk test distance in patients with systolic heart failure: insights from the WARCEF trial

Abstract Aims This study aimed to investigate the impact of baseline 6 min walk test distance (6MWTD) on time to major cardiovascular (CV) events in heart failure with reduced ejection fraction (HFrEF) and its impact in clinically relevant subgroups. Methods and results In the WARCEF (Warfarin versu...

Full description

Bibliographic Details
Main Authors: Kenji Matsumoto, Yi Xiao, Shunichi Homma, John L.P. Thompson, Richard Buchsbaum, Kazato Ito, Stefan D. Anker, Min Qian, Marco R. Di Tullio, for the WARCEF Investigators
Format: Article
Language:English
Published: Wiley 2021-04-01
Series:ESC Heart Failure
Subjects:
6 min walk test
Heart failure
Cardiovascular event
Prognosis
Online Access:https://doi.org/10.1002/ehf2.13068

Internet

https://doi.org/10.1002/ehf2.13068

Similar Items